Refractory pneumothorax secondary to COVID-19 treated by autologous blood patch pleurodesis.

Mitsuyama, Y; Tanaka, S; Ike, A; Tanaka, J; Fujimi, S

Mitsuyama, Y; Tanaka, S; Ike, A; Tanaka, J; Fujimi, S.

Mitsuyama Y; From the Division of Trauma and Surgical Critical Care, Osaka General Medical Center, 3-1-56 Bandai-Higashi, Sumiyoshi-ku, Osaka 558-8558, Japan.
Tanaka S; Department of Respiratory Medicine, Osaka General Medical Center, 3-1-56 Bandai-Higashi, Sumiyoshi-ku, Osaka 558-8558, Japan.
Ike A; Department of Thoracic Surgery, Osaka General Medical Center, 3-1-56 Bandai-Higashi, Sumiyoshi-ku, Osaka 558-8558, Japan.
Tanaka J; From the Division of Trauma and Surgical Critical Care, Osaka General Medical Center, 3-1-56 Bandai-Higashi, Sumiyoshi-ku, Osaka 558-8558, Japan.
Fujimi S; From the Division of Trauma and Surgical Critical Care, Osaka General Medical Center, 3-1-56 Bandai-Higashi, Sumiyoshi-ku, Osaka 558-8558, Japan.

QJM ; 114(11): 803-804, 2022 01 05.

Article in English | MEDLINE | ID: covidwho-1447622

Subject(s)

COVID-19; Pneumothorax; Humans; Pleurodesis; Pneumothorax/diagnostic imaging; Pneumothorax/etiology; Pneumothorax/therapy; SARS-CoV-2; Transplantation, Autologous

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumothorax / COVID-19 Limits: Humans Language: English Journal: QJM Journal subject: Medicine Year: 2022 Document Type: Article Affiliation country: Qjmed

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google